{
    "id": 4511,
    "name": "breast angiosarcoma",
    "source": "DOID",
    "definition": "An angiosarcoma and sarcoma of breast and vascular neoplasm of breast that is located_in the cells that line the blood vessels within the breast or underarm area. [url:http\\://breastcancer.about.com/od/types/p/angiosarcoma.htm]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:4511",
    "evidence": [
        {
            "id": 10800,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, analysis of radiation-associated breast angiosarcoma patients treated with Nexavar (sorafenib) demonstrated complete response in 22% (2/9) and partial response in 11% (1/9) of patients, with 30% (3/10) of the total group and 2 of 3 responders (3rd not evaluated) demonstrating FLT4 (VEGFR3) and MYC co-amplification (J Clin Oncol 30, 2012 (suppl; abstr 10019)).",
            "molecularProfile": {
                "id": 27804,
                "profileName": "FLT4 amp MYC amp"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 4511,
                "name": "breast angiosarcoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8825,
                    "pubMedId": null,
                    "title": "Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications.",
                    "url": "http://meetinglibrary.asco.org/content/92128-114"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        
    ]
}